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Background: An increasing number of conditions appear to benefit from control and modulation of temperature,
but available techniques to control temperature often have limitations, particularly in smaller patients with high
surface to mass ratios. We aimed to evaluate a new method of temperature modulation with an esophageal heat
transfer device in a pediatric swine model, hypothesizing that clinically significant modulation in temperature
(both increases and decreases of more than 1°C) would be possible.
Methods: Three female Yorkshire swine averaging 23 kg were anesthetized with inhalational isoflurane prior to
placement of the esophageal device, which was powered by a commercially available heat exchanger. Swine
temperature was measured rectally and cooling and warming were performed by selecting the appropriate
external heat exchanger mode. Temperature was recorded over time in order to calculate rates of temperature
change. Histopathology of esophageal tissue was performed after study completion.
Results: Average swine baseline temperature was 38.3°C. Swine #1 exhibited a cooling rate of 3.5°C/hr; however,
passive cooling may have contributed to this rate. External warming blankets maintained thermal equilibrium in
swine #2 and #3, demonstrating maximum temperature decrease of 1.7°C/hr. Warming rates averaged 0.29°C/hr.
Histopathologic analysis of esophageal tissue showed no adverse effects.
Conclusions: An esophageal heat transfer device successfully modulated the temperature in a pediatric swine
model. This approach to temperature modulation may offer a useful new modality to control temperature in
conditions warranting temperature management (such as maintenance of normothermia, induction of hypothermia,
fever control, or malignant hyperthermia).Background
Modifying or influencing the temperature of patients has
been shown to be important for a number of conditions.
Temperature modulation includes reduction of body
temperature below normal, maintenance of normal body
temperature for the avoidance of febrile or hyperthermic
states, and active warming of patients to avoid unin-
tended reductions of body temperature. The strength of
evidence for improved outcomes when temperature
modulation is implemented in several clinical scenarios
is such that it is now considered a standard of care,* Correspondence: kulstad@uic.edu
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unless otherwise stated.endorsed by major resuscitative, cardiovascular, neonatal,
and/or surgical standards groups (including the American
Heart Association, the International Liaison Committee
on Resuscitation, the European Resuscitation Council, the
National Institute of Child Health and Human Develop-
ment, the National Institute for Health and Care Excel-
lence, the Centers for Medicare and Medicaid Services via
the Surgical Care Improvement Project, and the American
Society of Anesthesiologists) [1-8]. In particular, adults
who remain comatose after resuscitation from cardiac
arrest, neonates suffering from hypoxic ischemic en-
cephalopathy, and patients undergoing general surgical
procedures longer than one hour in duration all have
strong recommendations for temperature modulation.
More broadly, temperature control has been shown ei-
ther preliminarily, or potentially, to be beneficial for
certain subsets of traumatic brain injury [9,10], spinal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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myocardial infarction [19-22], traumatic/hemorrhagic car-
diac arrest [23], surgical operations lasting longer than
one hour [24-29], hepatic encephalopathy [30-32], and
sepsis/septic shock [33]. The challenge of maintaining op-
erative normothermia during procedures on patients with
high surface to mass ratios, such as pediatric patients, is
significant, and many approaches are being developed to
address this need [34-36].
Leveraging the efficiencies of the heat transfer envir-
onment surrounding the esophagus, we have developed
a heat transfer device that offers a new approach for
modulation of patient temperature. The device is similar
in size to large orogastric tubes, and incorporates internal
channels to allow a closed circuit of water (serving as the
heat exchange medium) provided by an external heat
exchanger, with a central core serving as gastric access
(Figure 1). Specifically, the device consists of a total of
three lumens, one of which is isolated and serves as a
channel or conduit allowing direct gastric access for
suctioning and decompression, the other two of which
allow parallel countercurrent flow of coolant (water) which
is provided by the external chiller. Initial mathematical
modeling data [37] and animal data [38] have shown good
results in larger, adult-sized models; however, given the
additional challenges of modulating temperature in smaller
patients with larger surface to mass ratios, we sought to
evaluate the ability of this device to influence temperature
in a pediatric swine model, hypothesizing that clinically
significant modulation in temperature (both increases and
decreases) would be possible.
Methods
Animals
This prospective interventional study was performed by
an experienced team under a protocol approved by theFigure 1 Picture of esophageal heat transfer device.Institutional Animal Care and Use Committee (IACUC)
of Loyola University Medical Center. The study utilized
methods consistent with current veterinary and USDA
standards, with a state-of-the-art, Association for As-
sessment and Accreditation of Laboratory Animal Care
(AAALAC) International-accredited vivarium. Animal care
and handling was in accord with Office of Laboratory
Animal Welfare guidance for humane care and use of
animals and with regulations outlined in the USDA Animal
Welfare Act (9 CFR Parts 1, 2 and 3) and the conditions
specified in the Guide for the Care and Use of Laboratory
Animals (National Academy Press, Washington DC, 1996).
Animal experimentation was required to determine the
in vivo feasibility of modulating temperature with this ap-
proach, as in vitro models can only roughly approximate
human cardiovascular physiology. A swine model of the
size chosen has similarity in size, physiology, and thoracic
anatomy to pediatric patients.
Procedures
Three female Yorkshire swine weighing 21 kg, 22.5 kg,
and 24.6 kg, for a mean 22.7 kg ± 1.8 kg, were acclimated
to the facility as part of an unrelated dermal study inves-
tigating a small (2 square centimeter) region of skin for
a topical pharmaceutical. Animals were given 12 hours
food restriction but free access to water before the inter-
vention. Subjects were medicated with a pre-anesthetic
mix of Telazol (tiletamine/zolazepam) 4.4 mg/kg and
xylazine 2.0 mg/kg intramuscularly, endotracheally intu-
bated and anesthetized with 3% inhalational isoflurane
(with concentration adjusted as needed to maintain
anesthesia). No paralytics were used during any part
of the study. Normal saline was instilled at a mainten-
ance rate (2 cc/kg/hr) via ear vein. Continuous cardiac
monitoring was performed with a 3-lead EKG rhythm
recorder.
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The heat exchange device was connected to an external
heat exchange unit (Gaymar Medi-Therm III, Gaymar
industries, Inc., Orchard Park, New York) which uses
distilled water as the coolant, and the unit was powered
up. The tip of the device was lubricated with a water sol-
uble lubricant and inserted through the oropharynx into
the esophagus to a depth sufficient for the tip to rest in
the stomach. Adequate placement was confirmed by aus-
cultation of stomach sounds during insufflation of air
via syringe, followed by withdrawal of stomach contents
through the central gastric access pathway within the
device. The heat exchange unit was operated in patient
control mode, in which the Medi-Therm III machine
automatically regulates the patient’s temperature to the
selected set point. The machine constantly compares
actual patient temperature with the set point value, and
automatically adjusts the water temperature so that the
desired patient temperature is achieved.
Measurements
Temperature was recorded with a YSI-400 series com-
patible rectal temperature probe which was connected
to the input patient probe connector on the external heat
exchange unit, providing a continuous digital display of
each subject’s temperature. In the first swine, we attempted
to determine a maximum rate of temperature decrease
from baseline to a goal temperature (4°C below baseline)
by switching the external chiller to a maximum cooling
mode 30 minutes after beginning the experiment. How-
ever, a baseline decrease in temperature was observed even
prior to initiation of cooling with the experimental device
(Figure 2). This outcome was attributed to cold laboratory
conditions, including a fixed air vent blowing cold air into
the laboratory, a cold metal laboratory table surface, and
an uncovered animal. Additional measures, as discussed in
the Results section below, where then undertaken to
compensate for these conditions.Figure 2 Temperature over time for Swine #1.Results
Although the first subject demonstrated a maximum
temperature decrease of 3.5°C/hr, passive cooling theor-
etically may have contributed up to 1.8°C/hr of this rate.
Likewise, due to passive losses in the cold laboratory en-
vironment, upon switching the chiller to warming mode
at 83 minutes, additional decreases in temperature were
seen (albeit at a much slower rate). In order to achieve
full reversal of temperature decrease, the subject was cov-
ered at 155 minutes, and warm IV fluids were substituted
for the room temperature fluids initially administered at
165 minutes into the protocol. These measures were suffi-
cient to counteract the ongoing passive heat losses and re-
sulted in a demonstrable increase in temperature (at a rate
of 0.34°C/hr). Finally, at 243 minutes into the protocol, an
external heated water blanket was applied and set to 39°C,
resulting in further increase in the rate of temperature
gain (to a rate of 0.95°C/hr).
To compensate for the substantial ambient heat losses
encountered in the laboratory, body temperature was
stabilized prior to initiating cooling in the subsequent 2
swine. Stabilization methods included passive warming
in the form of blankets to provide skin surface coverage,
and using warmed IV fluids throughout the protocol.
Once temperature was stabilized (68 minutes into the
protocol for swine #2, shown in Figure 3, and 63 minutes
into the protocol for swine #3, shown in Figure 4), the
external heat exchanger was set to cooling mode, and
temperature was monitored until goal temperature of
4°C below baseline was attained, at which point the ex-
ternal heat exchanger was set to a warming mode.
Swine #2 and #3 exhibited temperature decreases of
1.7°C/hr. Cooling was successfully stopped and reversed
at the end of the protocol in both cases through the use
of the heat exchanger set to warming mode (although
technician availability limited the length of time avail-
able for monitoring and precluded a complete return to
baseline temperature prior to sacrifice). Warming rates
achieved were 0.25°C/hr and 0.29°C/hr, respectively.
Histopathology of the esophagus of all three animals,
performed after necropsy by a certified veterinary path-
ologist immediately after device removal using standard
microscopic evaluation of thin sections of tissues, re-
vealed normal tissue without evidence of injury.
Discussion
Although a variety of approaches currently exist for con-
trolling a patient’s temperature, many have inherent lim-
itations. Surface devices are cumbersome, uncomfortable
to surrounding operative staff, and of limited effective-
ness when removed to gain access for surgical proce-
dures. Intravascular catheters require sterile placement
into the vasculature and the consequent risk of blood
clots or infections. Controlling a patient’s temperature
Figure 3 Temperature over time for Swine #2.
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with varying degrees of efficacy, both for cooling [39-42]
and for warming [43-46] using various techniques and
approaches. Using a free installation of liquid (water, or
normal saline) that is either cooled with ice or warmed
as appropriate for the intended effect has been the most
common method of temperature control through the
gastrointestinal tract, and is utilized as a mechanism of
inducing therapeutic hypothermia in various hospitals
[47,48]. Warming efforts in the past have been less suc-
cessful [46], and interest in this approach to temperature
management specifically for warming appears to have di-
minished after publication of a letter which our research
group recently found to contain an incorrect mathemat-
ical analysis [49]. In the device evaluated in this report,
liquid is contained in a closed circuit system, avoidingFigure 4 Temperature over time for Swine #3.the risks and potential complications of instilling free li-
quid into the gastrointestinal system. Additionally, the
device tested in this investigation likely leverages more
advanced materials, design specifications, and tolerances
than were available in earlier investigations, allowing for
greater performance and efficiency than has been achieved
in earlier attempts to induce temperature change through
the gastrointestinal tract.
We encountered greater ambient heat loss than initially
expected. Cold laboratory conditions, combined with the
small size of the swine, caused an unexpectedly high rate
of heat loss, prompting the use of passive (blankets) as
well as active (warmed IV fluids) warming methods to
compensate. This permitted a more accurate determin-
ation of the cooling capability of the device, but limits
the ability to make definitive conclusions regarding the
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device alone would not be sufficient to counter the threat
of perioperative hypothermia in the most extreme cases
(prolonged surgeries with extensive thoraco-abdominal
exposure, for example); however, this esophageal heat
transfer approach may be useful as an adjunct to these
cases, and in less intense heat-loss situations, may be
sufficient as the sole modality to avoid inadvertent peri-
operative hypothermia.
Placement of a device into the esophagus for the pur-
pose of controlling patient temperature is more invasive
than the use of external surface heat transfer devices; how-
ever, as compared with intravascular catheter devices used
for this purpose, an esophageal approach can be con-
sidered less invasive. Additionally, an esophageal device
requires no sterility for placement, and many patients
undergoing temperature management, such as in the
intensive care unit or operating room, receive a stand-
ard nasogastric or orogastric tube anyway.
Limitations of this investigation include the small sam-
ple size utilized. Although a larger sample would provide
more refined data, the current data generally support
the hypothesis that clinically significant modulations in
temperature are possible in a pediatric model, and sug-
gest that this may hold true in pediatric patients as well.
Isoflurane may have contributed to systemic vasodilation
and consequent increase in heat loss to the environment,
particularly at the upper ranges of concentration utilized.
We only measured temperature rectally, and rectal
temperatures are known to lag those obtained from ei-
ther bladder or intravascular means. Nevertheless, the
expected differences in rates of temperature change are
unlikely to affect our overall conclusions on the ability
of this approach to have the intended effect on body
temperature.
Conclusions
In conclusion, we found that an esophageal heat transfer
device successfully modulated the temperature of a
pediatric swine model. This approach to temperature
modulation may offer a useful new modality to control
temperature in conditions warranting temperature man-
agement, such as maintenance of normothermia during
surgery, induction of hypothermia for a growing number
of indications (cardiac arrest, hypoxic ischemic enceph-
alopathy, traumatic brain or spinal cord injury, stroke,
etc.), fever control, or in the treatment of malignant
hyperthermia.
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